XTL Biopharmaceuticals/$XTLB
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About XTL Biopharmaceuticals
XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.
Ticker
$XTLB
Sector
Primary listing
Employees
10
Headquarters
Ramat Gan, Israel
Website
XTLB Metrics
BasicAdvanced
$5.5m
-
-$0.01
0.73
-
Price and volume
Market cap
$5.5m
Beta
0.73
52-week high
$4.87
52-week low
$2.01
Average daily volume
31k
Financial strength
Current ratio
0.7
Quick ratio
0.459
Total debt to equity
-182.979
Interest coverage (TTM)
-119.78%
Profitability
Gross margin (TTM)
-232.85%
Net profit margin (TTM)
-651.65%
Operating margin (TTM)
-618.70%
Effective tax rate (TTM)
5.24%
Revenue per employee (TTM)
$100,000
Management effectiveness
Return on assets (TTM)
-240.56%
Return on equity (TTM)
-577.13%
Valuation
Price to revenue (TTM)
2,104.348
Price to book
-320.75
Price to tangible book (TTM)
-320.75
Growth
Earnings per share change (TTM)
548.14%
3-year earnings per share growth (CAGR)
52.08%
10-year earnings per share growth (CAGR)
-3.36%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs